ScoreWhy is Bliss GVS Pharma Ltd ?
1
The company is Net-Debt Free
2
With a growth in Net Sales of 37.65%, the company declared Very Positive results in Jun 26
- The company has declared positive results for the last 2 consecutive quarters
- OPERATING CF(Y) Highest at Rs 138.72 Cr
- PBT LESS OI(Q) At Rs 65.88 cr has Grown at 138.18%
- ROCE(HY) Highest at 16.80%
3
Increasing Participation by Institutional Investors
- Institutional investors have increased their stake by 2.05% over the previous quarter and collectively hold 17.54% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
4
Consistent Returns over the last 3 years
- Along with generating 336.82% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Bliss GVS Pharma should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Bliss GVS Pharma for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Bliss GVS Pharma
339.48%
5.61
60.51%
Sensex
-9.4%
-0.70
13.49%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
10.30%
EBIT Growth (5y)
9.42%
EBIT to Interest (avg)
15.70
Debt to EBITDA (avg)
0.68
Net Debt to Equity (avg)
-0.12
Sales to Capital Employed (avg)
0.74
Tax Ratio
29.82%
Dividend Payout Ratio
4.10%
Pledged Shares
0
Institutional Holding
17.54%
ROCE (avg)
12.39%
ROE (avg)
9.73%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
50
Industry P/E
37
Price to Book Value
5.82
EV to EBIT
41.44
EV to EBITDA
34.11
EV to Capital Employed
6.49
EV to Sales
6.76
PEG Ratio
1.80
Dividend Yield
0.23%
ROCE (Latest)
12.48%
ROE (Latest)
10.95%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Bullish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend26What is working for the Company
OPERATING CF(Y)
Highest at Rs 138.72 Cr
PBT LESS OI(Q)
At Rs 65.88 cr has Grown at 138.18%
ROCE(HY)
Highest at 16.80%
NET SALES(Q)
At Rs 285.58 cr has Grown at 37.65%
PBDIT(Q)
Highest at Rs 76.41 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 26.76%
PAT(Q)
Highest at Rs 50.10 cr.
EPS(Q)
Highest at Rs 4.72
-3What is not working for the Company
DPR(Y)
Lowest at 4.10%
Loading Valuation Snapshot...
Here's what is working for Bliss GVS Pharma
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 65.88 cr has Grown at 138.18%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Operating Cash Flow - Annually
Highest at Rs 138.72 Cr and Grown
each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (Rs Cr)
Net Sales - Quarterly
Highest at Rs 285.58 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 285.58 cr has Grown at 37.65%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 76.41 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 26.76%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 65.88 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 50.10 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 4.72
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Bliss GVS Pharma
Dividend Payout Ratio (DPR) - Annually
Lowest at 4.10% and Fallen
each year in the last five yearsMOJO Watch
Company is distributing lower proportion of profits generated as dividend
DPR (%)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
